Survey of the commercial value and sale of biotech pharmaceutical products

In the past two decades، given the importance of biotech drugs and its effective role in the treatment of many diseases، the commercialization and selling of these products is dramatically grown worldwide and many large companies have obtained macro-economic benefits for their own and their mother country by investing in this area. The United States is the largest investor in the research، production and sales of pharmaceutical products derived from biotechnology; therefore، studying the biotechnological drugs market can provide an overall vision about the commercialization process and the market for these types of drugs in the world. For the young researchers in biotechnology and pharmaceutical field to be familiar with commercial status and sales of biotechnological drugs، the business development and selling of these products in the United States in a period of 10 years (2002-2012) was studied as a reference model. Data presented in this article is based on the reports from 2007 to 2014، which are published in each year in the Nature Biotechnology Journal.